Skip to main content

Articles

Page 8 of 13

  1. Authors: P Whiley, LC Walker, M De LA Hoya, B Wappenschmidt, A Becker, A Blanco, MJ Blok, MA Caligo, C Chatfield, F Couch, O Diez, L Fachal, L Guidugli, S Gutiérrez Enríquez, T Hansen, C Houdayer…

    Citation: Hereditary Cancer in Clinical Practice 2012 10(Suppl 2):A87

    Content type: Meeting abstract

    Published on:

    This article is part of a Supplement: Volume 10 Supplement 2

  2. Authors: Jonathan Beesley, Hilda Pickett, Sharon Johnatty, Xiaoqing Chen, Jun Jun Li, David Rider, Michael Stutz, Diether Lambrecht, Jenny Chang-Claude, Thilo Dork, Marc Goodman, Bart Kiemmney, Elisa Bandera, Linda Kelemen, Shan Wang-Gorke, Ian Campbell…

    Citation: Hereditary Cancer in Clinical Practice 2012 10(Suppl 2):A86

    Content type: Meeting abstract

    Published on:

    This article is part of a Supplement: Volume 10 Supplement 2

  3. Authors: MC Southey, DJ Park, F Lesueur, F Odefrey, T Nguyen-Dumont, F Hammet, SL Neuhausen, EM John, IL Andrulis, G Chenevix-Trench, L Baglietto, F Le Calvez-Kelm, M Pertesi, A Lonie, B Pope, O Sinilnikova…

    Citation: Hereditary Cancer in Clinical Practice 2012 10(Suppl 2):A40

    Content type: Meeting abstract

    Published on:

    This article is part of a Supplement: Volume 10 Supplement 2

  4. Authors: Georgia Chenevix-Trench, Yi Lu, Sharon Johnatty, Eric Gamazon, Jonathan Beesley, Xiaoqing Chen, Bo Gao, Paul Harnett, R Stephanie Huang, Evelyn Despierre, Florian Heitz, Estrid Hogdall, Claus Hogdall, Robert Brown, Kirsten Moyisch, Peter Fasching…

    Citation: Hereditary Cancer in Clinical Practice 2012 10(Suppl 2):A36

    Content type: Meeting abstract

    Published on:

    This article is part of a Supplement: Volume 10 Supplement 2

  5. Authors: Bente A Talseth-Palmer, Juul T Wijnen, Ingvild S Brenne, Shantie Jagmohan-Changur, Katie A Ashton, Carli M Tops, Tiffany-Jane Evans, Mary McPhillips, Claire Groombridge, Janina Suchy, Grzegorz Kurzawski, Allan Spigelman, Pål Møller, Hans M Morreau, Tom Van Wezel, Jan Lubinski…

    Citation: Hereditary Cancer in Clinical Practice 2012 10(Suppl 2):A32

    Content type: Meeting abstract

    Published on:

    This article is part of a Supplement: Volume 10 Supplement 2

  6. Individuals who carry deleterious BRCA mutations face significantly elevated risks of breast, ovarian, and other cancers. These individuals are also responsible for informing relatives of their increased risk ...

    Authors: Ani Kardashian, Julia Fehniger, Jennifer Creasman, Eleanor Cheung and Mary Stanley Beattie

    Citation: Hereditary Cancer in Clinical Practice 2012 10:4

    Content type: Research

    Published on:

  7. Germline mutations in p53 are associated with the Li-Fraumeni Syndrome which is characterized by childhood cancers, including pediatric adrenal cortical carcinomas and early onset breast cancer. The high incid...

    Authors: Magda CB Gomes, Joanne Kotsopoulos, Gutemberg Leão de Almeida, Mauricio M Costa, Roberto Vieira, Firmino de AG Filho, Marcos B Pitombo, Paulo Roberto F Leal, Robert Royer, Phil Zhang and Steven A Narod

    Citation: Hereditary Cancer in Clinical Practice 2012 10:3

    Content type: Research

    Published on:

  8. Testicular cancer, while rare compared with other adult solid tumors, is the most common cancer in young men in northern Europe and North America. Risk factors include white race, positive family history, cont...

    Authors: June A Peters, Regina Kenen, Lindsey M Hoskins, Gladys M Glenn, Christian Kratz and Mark H Greene

    Citation: Hereditary Cancer in Clinical Practice 2012 10:2

    Content type: Research

    Published on:

  9. Authors: J Lubiński, T Huzarski, A Jakubowska, J Gronwald, K Jaworska, M Muszyńska, G Sukiennicki, K Durda, C Cybulski, T Dębniak, A Tołoczko, O Oszurek, P Serrano-Fernandez, R Scott and S Narod

    Citation: Hereditary Cancer in Clinical Practice 2012 10(Suppl 1):A11

    Content type: Meeting abstract

    Published on:

    This article is part of a Supplement: Volume 10 Supplement 1

  10. About 5-10% of breast and ovarian carcinomas are hereditary and most of these result from germline mutations in the BRCA1 and BRCA2 genes. In women of Ashkenazi Jewish ascendance, up to 30% of breast and ovarian ...

    Authors: Ingrid P Ewald, Patrícia Izetti, Fernando R Vargas, Miguel AM Moreira, Aline S Moreira, Carlos A Moreira-Filho, Danielle R Cunha, Sara Hamaguchi, Suzi A Camey, Aishameriane Schmidt, Maira Caleffi, Patrícia Koehler-Santos, Roberto Giugliani and Patricia Ashton-Prolla

    Citation: Hereditary Cancer in Clinical Practice 2011 9:12

    Content type: Research

    Published on:

  11. We assessed ovarian cancer screening outcomes in women with a positive family history of ovarian cancer divided into a low-, moderate- or high-risk group for development of ovarian cancer.

    Authors: Marielle AE Nobbenhuis, Elizabeth Bancroft, Eleanor Moskovic, Fiona Lennard, Paul Pharoah, Ian Jacobs, Ann Ward, Desmond PJ Barton, Thomas EJ Ind, John H Shepherd, Jane E Bridges, Martin Gore, Chris Haracopos, Susan Shanley, Audrey Ardern-Jones, Sarah Thomas…

    Citation: Hereditary Cancer in Clinical Practice 2011 9:11

    Content type: Research

    Published on:

  12. Inheritance of a mutation in either BRCA1 or BRCA2 accounts for approximately 5% of all breast cancer cases, but varies by country. Investigations into the contribution of BRCA mutations to breast cancer incidenc...

    Authors: Chrissovaladis Koumpis, Constantine Dimitrakakis, Aris Antsaklis, Robert Royer, Shiyu Zhang, Steven A Narod and Joanne Kotsopoulos

    Citation: Hereditary Cancer in Clinical Practice 2011 9:10

    Content type: Research

    Published on:

  13. Perforin gene (PRF1) mutations have been identified in some patients diagnosed with the familial form of hemophagocytic lymphohistiocytosis (HLH) and in patients with lymphoma. The aim of the present study was to...

    Authors: Rim El Abed, Violaine Bourdon, Ilia Voskoboinik, Halima Omri, Yosra Ben Youssef, Mohamed Adnene Laatiri, Laetitia Huiart, François Eisinger, Laetitia Rabayrol, Marc Frenay, Paul Gesta, Liliane Demange, Hélène Dreyfus, Valérie Bonadona, Catherine Dugast, Hélène Zattara…

    Citation: Hereditary Cancer in Clinical Practice 2011 9:9

    Content type: Research

    Published on:

  14. Lynch syndrome is a hereditary cancer with confirmed carriers at high risk for colorectal (CRC) and extracolonic cancers. The purpose of the current study was to develop a greater understanding of the factors ...

    Authors: Kathy E Watkins, Christine Y Way, Jacqueline J Fiander, Robert J Meadus, Mary Jane Esplen, Jane S Green, Valerie C Ludlow, Holly A Etchegary and Patrick S Parfrey

    Citation: Hereditary Cancer in Clinical Practice 2011 9:8

    Content type: Research

    Published on:

  15. The perception of breast cancer risk held by women who have not had breast cancer, and who are at increased, but unexplained, familial risk of breast cancer is poorly described. This study aims to describe ris...

    Authors: Louise A Keogh, Belinda J McClaren, Carmel Apicella and John L Hopper

    Citation: Hereditary Cancer in Clinical Practice 2011 9:7

    Content type: Research

    Published on:

  16. Neurofibroma occurs as isolated or multiple lesions frequently associated with neurofibromatosis type 1 (NF1), a common autosomal dominant disorder affecting 1 in 3500 individuals. It is caused by mutations in...

    Authors: Giovanni Ponti, Lorena Losi, Davide Martorana, Manuela Priola, Elisa Boni, Annamaria Pollio, Tauro Maria Neri and Stefania Seidenari

    Citation: Hereditary Cancer in Clinical Practice 2011 9:6

    Content type: Research

    Published on:

  17. Tumors arising in patients with hereditary cancer syndromes may have distinct drug sensitivity as compared to their sporadic counterparts. Breast and ovarian neoplasms from BRCA1 or BRCA2 mutation carriers are ch...

    Authors: Evgeny N Imyanitov and Vladimir M Moiseyenko

    Citation: Hereditary Cancer in Clinical Practice 2011 9:5

    Content type: Review

    Published on:

  18. Risk perception is considered a motivating factor for adopting preventive behaviors. This study aimed to verify the demographic characteristics and cancer family history that are predictors of risk perception ...

    Authors: Erika M Santos, Maria TC Lourenço and Benedito M Rossi

    Citation: Hereditary Cancer in Clinical Practice 2011 9:4

    Content type: Research

    Published on:

  19. The BRCA1/2 genes account for a significant portion of hereditary breast and ovarian cancers and they are especially prevalent in the Ashkenazi Jewish population. Women who have a mutation can prevent breast a...

    Authors: Katherine H Saunders, Shivani Nazareth and Peter I Pressman

    Citation: Hereditary Cancer in Clinical Practice 2011 9:3

    Content type: Case report

    Published on:

Annual Journal Metrics